Generic Gilteritinib vs. XOSPATA: Is There a Difference in Quality?
For many AML patients, the cost of maintenance therapy is the biggest barrier to health. When doctors prescribe Gilteritinib (brand name Xospata®), the price tag can be shocking.
What Does “Bioequivalent” Mean?
Generic medicines, like Gilternib (Everest Pharma), must be “bioequivalent.” This means they must deliver the same amount of active ingredient (Gilteritinib) into the bloodstream at the same speed as the brand-name drug.
Why is the generic low cost?
The brand-name manufacturer spent billions on Research & Development (R&D) and marketing. Generic manufacturers, like Everest Pharmaceutical, do not have these R&D costs; they only pay for manufacturing and quality testing. They pass these savings on to the patient.
Regulatory Standards
High-quality generics are approved by regulatory bodies (like the FDA or local equivalents). They are manufactured in facilities that adhere to cGMP (Current Good Manufacturing Practice) standards.
Conclusion
You do not have to compromise on your health to save money. Generic Gilteritinib offers a viable pathway to continuous treatment.
Learn more about the importance of FLT3 inhibitors in our Complete Guide to FLT3 AML Therapy.
